SCHEMBL2172884

SCHEMBL2172884

C=C(c1ccccc1)N1CCCC1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
HPGD P15428 2/20 0.44
CYP3A4 P08684 1/20 0.44
POLB P06746 2/20 0.43
MAPT P10636 4/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
RECQL P46063 3/20 0.43
KDM4E B2RXH2 1/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14539264 0.83 MAPT (0.44) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL27551581 0.81 MAPT (0.50) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL31472654 0.81 SMN1; SMN2 (0.49) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL31472659 0.81 HPGD (0.47) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL14539261 0.81 MEN1 (0.45) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1002469 0.80 CYP1A2 (0.64) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL31472651 0.79 MAPT (0.71) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL27926889 0.79 KMT2A (0.41) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
Water SCHEMBL27387795 0.79 CYP1A2 (0.62) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL27988603 0.78 MAPT (0.40) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025041761-A1 PHOTOCURABLE COMPOSITION FOR ADHESIVE SHEET, ADHESIVE SHEET, OPTICAL LAMINATE, AND IMAGE DISPLAY DEVICE 日東電工株式会社 2025-02-27 WO disclosed
WO-2025022816-A1 PRESSURE-SENSITIVE ADHESIVE SHEET, OPTICAL LAMINATE, AND IMAGE DISPLAY DEVICE 日東電工株式会社 2025-01-30 WO disclosed
WO-2024203367-A1 PHOTOCURABLE COMPOSITION FOR PRESSURE-SENSITIVE ADHESIVE SHEET, PRESSURE-SENSITIVE ADHESIVE SHEET, OPTICAL LAMINATE, AND IMAGE DISPLAY DEVICE 日東電工株式会社 2024-10-03 WO disclosed
WO-2024203366-A1 PHOTOCURABLE COMPOSITION FOR ADHESIVE SHEET, ADHESIVE SHEET, OPTICAL LAMINATE, AND IMAGE DISPLAY DEVICE 日東電工株式会社 2024-10-03 WO disclosed
WO-2024203364-A1 PRODUCTION METHOD FOR ADHESIVE SHEET, PRODUCTION METHOD FOR OPTICAL FILM WITH ADHESIVE SHEET, AND PRODUCTION METHOD FOR IMAGE DISPLAY DEVICE 日東電工株式会社 2024-10-03 WO disclosed
WO-2024203369-A1 POLARIZING FILM WITH ADHESIVE SHEET, OPTICAL LAMINATE AND IMAGE DISPLAY DEVICE 日東電工株式会社 2024-10-03 WO disclosed
WO-2024203368-A1 POLARIZING FILM EQUIPPED WITH ADHESIVE SHEET, OPTICAL LAMINATE, AND IMAGE DISPLAY DEVICE 日東電工株式会社 2024-10-03 WO disclosed
WO-2024203365-A1 PRODUCTION METHOD FOR PRESSURE-SENSITIVE ADHESIVE SHEET, PRODUCTION METHOD FOR OPTICAL FILM WITH PRESSURE-SENSITIVE ADHESIVE SHEET, AND PRODUCTION METHOD FOR IMAGE DISPLAY DEVICE 日東電工株式会社 2024-10-03 WO disclosed
WO-2020108500-A1 HISTONE ACETYLASE P300 INHIBITOR AND USE THEREOF 成都海创药业有限公司 2020-06-04 WO disclosed
US-7973162-B2 Modulators of muscarinic receptors VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-05 US disclosed
EP-2207549-A1 MODULATORS OF MUSCARINIC RECEPTORS Vertex Pharmceuticals Incorporated (US) 2010-07-21 EP disclosed
US-20090099222-A1 Modulators of muscarinic receptors VERTEX PHARMACEUTICALS INCORPORATED 2009-04-16 US disclosed
WO-2009045519-A1 MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-04-09 WO disclosed
US-4139633-A ISOPROPYLAMINOPROPANE DERIVATIVES, SUBSTITUTED BENZENE SULPHONAMIDE CIBA-GEIGY CORPORATION (US) 1979-02-13 US disclosed
US-3937834-A ALPHA-RECEPTOR BLOCKER, BETA-RECEPTOR BLOCKER, HIGH BLOOD PRESSURE, ANGINA PECTORIS CIBA-GEIGY CORPORATION (US) 1976-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099222-A1 Modulators of muscarinic receptors CHRM3, CHRM5, CHRM2 ALDH1A1 2356/4885CYP1A2 1140/4885CYP2D6 1646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.